For instance, olmesartan can suppress Fas-mediated apoptosis and enhance LV remodeling postmyocardial infarction.[98] Similarly, Simvastatin can decrease apoptosis of cardiomyocytes and enhance cardiac function after myocardial infarction. Here, FAS is linked to myocardial infarction.